Home Photos Surgery Types Cosmetic Surgeons Surgery Prices Surgery Risks Plastic Surgery News

Sanofi withdraws anti-obesity drug in US (AFP)

Senior Executive Vice President of Sanofi Aventis, Gerard Le Fur, holds a February 2007 press conference in Paris, to present the 2006 results of the French pharmaceutical group.Sanofi-Aventis said Friday it had withdrawn an application for regulatory approval for its anti-obesity drug Acomplia in the United States.(AFP/File/Martin Bureau)AFP - French pharmaceutical group Sanofi-Aventis said Friday it had withdrawn an application for regulatory approval for its anti-obesity drug Acomplia in the United States.


More: continued here





You can respond, or trackback from your own site.


Related News

  • Key US drug panel rejects Sanofi's obesity pill (AFP)
  • Panel rejects new weight-loss drug (AP)
  • Sanofi pulls obesity drug application in U.S. (Reuters)
  • Sanofi obesity drug faces tough EU safety review (Reuters)
  • Controversial obesity drug gets UK okay (Reuters)
  • Panel rejects Sanofi obesity drug (Reuters)
  • Medtronic Receives Approval for First Artificial Disc for the Neck in the United States (Finanzen.net)
  • Medtronic Receives Approval for First Artificial Disc for the Neck in the United States (FinanzNachrichten)
  • New Report Examines the Causes and Consequences of Adult Obesity in the United States (Business Wire via Yahoo! Finance)
  • Alcon Gets FDA Nod For Triesence Drug Forbes


    • Leave a Reply
    Cosmetic Surgery Procedure.com | Cosmetic Surgery Types | Find a Cosmetic Surgeon | Cosmetic Surgery Prices | Cosmetic Surgery Risks | Resources | Contact Us